PMC:7195088 / 61307-61489 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"1830","span":{"begin":103,"end":111},"obj":"Species"},{"id":"1831","span":{"begin":117,"end":125},"obj":"Disease"}],"attributes":[{"id":"A1830","pred":"tao:has_database_id","subj":"1830","obj":"Tax:9606"},{"id":"A1831","pred":"tao:has_database_id","subj":"1831","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"suppressive and/or immunomodulatory therapies be administered?\nAccording to some recent evidence, some patients with COVID-19 may develop secondary haemophagocytic lymphohistiocytosi"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T356","span":{"begin":117,"end":125},"obj":"Disease"}],"attributes":[{"id":"A356","pred":"mondo_id","subj":"T356","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"suppressive and/or immunomodulatory therapies be administered?\nAccording to some recent evidence, some patients with COVID-19 may develop secondary haemophagocytic lymphohistiocytosi"}